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and	 a	major	 cause	of	 cancer-related	mortality.	 The	 importance	of	 lifestyle	 and	diet	 as	major	
determinants	of	CRC	risk	is	suggested	by	differences	in	CRC	incidence	between	countries	and	in	
migration	 studies.	 Previous	observational	 epidemiological	 studies	have	 identified	associations	
between	modifiable	environmental	risk	factors	and	CRC,	but	these	studies	can	be	susceptible	to	
reverse	 causation	 and	 confounding,	 and	 their	 results	 can	 therefore	 conflict.	 Mendelian	
randomisation	 (MR)	 analysis	 represents	 an	 approach	 complementary	 to	 conventional	
observational	studies	examining	associations	between	exposures	and	disease.	The	MR	strategy	
employs	 allelic	 variants	 as	 instrumental	 variables	 (IVs),	 which	 act	 as	 proxies	 for	 non-genetic	
exposures.	 These	 allelic	 variants	 are	 randomly	 assigned	 during	 meiosis	 and	 can	 therefore	
inform	on	life-long	exposure,	whilst	not	being	subject	to	reverse	causation.	In	previous	studies	













Colorectal	 cancer	 (CRC)	 is	 one	 of	 the	 most	 common	 cancers	 in	 economically	 developed	
countries	and	a	major	 cause	of	 cancer-related	mortality	 (Forman	et	al.,	 2014).	 The	disease	 is	
currently	diagnosed	in	over	one	million	individuals	worldwide	annually;	although	its	incidence	is	
set	to	rise	in	developing	countries	with	the	adoption	of	western	lifestyles	and	diets	(Haggar	and	
Boushey,	2009).	 The	 importance	of	 lifestyle	and	diet	 as	major	determinants	of	CRC	 risk	have	
been	 strongly	 suggested	 by	 geographical	 differences	 in	 CRC	 incidence	 and	 demonstrated	 in	
migration	studies	(Kamangar	et	al.,	2006).	Given	the	importance	of	these	factors	in	CRC	risk,	the	
modification	 of	 lifestyle	 and	 diet	 through	 public	 health	 initiatives	 offers	 the	 prospect	 of	
significant	impact	on	CRC	incidence.	The	full	compendium	of	exposures	affecting	CRC	risk,	and	








the	 disease	 (Winawer	 et	 al.,	 1997).	 The	 lifetime	 risk	 for	 CRC	 in	 Western	 populations	 is	
approximately	4%	(Siegel	et	al.,	2017),	although	this	risk	is	almost	doubled	in	individuals	with	a	
first-degree	 family	member	 diagnosed	with	 CRC,	 and	 tripled	 in	 individuals	with	 two	 or	more	
affected	 family	members	 (Taylor	et	al.,	 2010).	 Epidemiological	 studies	have	provided	 support	
for	a	hereditary	component	to	the	aetiology	of	a	large	number	of	cancers,	including	CRC	(Risch,	
2001).	 For	 many	 cancers,	 a	 higher	 concordance	 in	 monozygotic	 twins	 as	 compared	 with	
dizygotic	 twins,	 or	 with	 siblings,	 has	 been	 observed	 (Lichtenstein	 et	 al.,	 2000).	 Whilst	 such	




Technological	 developments	 in	 high-throughput	 genotyping	 and	 improved	 understanding	 of	
common	 genetic	 variation	 have	 made	 genome-wide	 association	 studies	 (GWAS)	 possible,	
facilitating	the	identification	of	single	nucleotide	polymorphisms	(SNPs)	influencing	cancer	risk	
(Sud	 et	 al.,	 2017).	 So	 far,	 GWAS	 have	 identified	 approximately	 100	 SNPs	 independently	
associated	 with	 CRC	 risk	 (Al-Tassan	 et	 al.,	 2015;	 Broderick	 et	 al.,	 2007;	 Cogent	 Study	 et	 al.,	
2008;	Dunlop	et	al.,	2012;	Houlston	et	al.,	2010;	Kinnersley	et	al.,	2012;	Orlando	et	al.,	2016;	
Schumacher	et	al.,	2015;	Tenesa	et	al.,	2008;	Tomlinson	et	al.,	2007;	Whiffin	et	al.,	2014),	with	
the	 largest	study	to-date	combining	data	from	over	125,000	 individuals	 (Huyghe	et	al.,	2018).	







evidence	 is	 reported	 for	 factors	 including	obesity,	 height,	 alcohol	 intake	 and	 consumption	of	
red	 and	 processed	 meats	 increasing	 CRC	 risk.	 The	 evidence	 that	 low	 intake	 of	 non-starchy	






Increased	 CRC	 risk	 has	 also	 been	 associated	 with	 chronic	 colitis	 due	 to	 inflammatory	 bowel	
disease	(IBD)	(Lu	et	al.,	2018).	The	longer	the	duration	of	IBD,	the	greater	the	increase	in	CRC	
risk	(Lu	et	al.,	2018).	However,	whilst	 IBD	is	thought	to	 increase	risk	of	CRC,	 it	explains	only	a	
small	 proportion	 of	 CRC	 incidence	 in	 Western	 populations	 (Kuipers	 et	 al.,	 2015).	 Improved	
surveillance	 and	 the	 increasing	 effectiveness	 of	 anti-inflammatory	 treatments	 may	 also	 be	
lowering	 the	 incidence	 of	 CRC	 in	 those	 with	 IBD	 (Jess	 et	 al.,	 2012).	 Heavy	 smoking	 over	 a	
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socioeconomic	 and	 geographic	 differences	 in	 CRC	 rates	 (Doubeni	 et	 al.,	 2012).	 It	 has	 been	
estimated	that	as	many	as	71%	of	CRCs	in	Western	countries	may	be	due	to	these	modifiable	
exposures	 and	 therefore	 preventable	 (Platz	 et	 al.,	 2000).	 However,	 to	 reduce	 CRC	 incidence	







So	 far,	 many	 studies	 attempting	 to	 evaluate	 relationships	 between	 possible	 risk	 factors	 and	
diseases,	 such	as	CRC,	have	 relied	upon	observational	 case-control,	 cohort,	or	 cross-sectional	
study	 designs	 (Lawlor	 et	 al.,	 2004).	 Whilst	 observational	 studies	 have	 seemingly	 robustly	
associated	a	risk	factor	and	a	disease,	 interventions	modifying	such	risk	factors	do	not	always	
results	 in	 the	 anticipated	 change	 in	 disease	 incidence	 (Davey	 Smith	 and	 Hemani,	 2014).	 A	
number	 of	 explanations	 for	 these	 ostensibly	 paradoxical	 observations	 have	 been	 suggested,	
including	 the	 susceptibility	of	observational	epidemiological	 studies	 to	 certain	biases,	 such	as	
reverse	 causation,	 confounding	 and	 errors	 in	 measurement.	 These	 biases	 can	 result	 in	 an	
apparent	 association	 between	 a	 risk	 factor	 and	 a	 disease,	 without	 the	 existence	 of	 a	 direct	
causal	relationship.		
	
Reverse	 causation	 occurs	 when	 the	 postulated	 risk	 factor	 does	 not	 itself	 influence	 disease	
development,	but	 instead	the	occurrence	of	 the	disease	affects	 the	postulated	risk	 factor.	An	
example	of	possible	reverse	causation	is	in	the	relationship	between	computerized	tomography	
(CT)	 scans	and	cancer	 (Mathews	et	al.,	2013).	 	Higher	cancer	 incidence	has	been	observed	 in	
	 6	
individuals	 exposed	 to	 low-dose	 ionizing	 radiation	 from	diagnostic	 CT	 scans	 (Mathews	 et	 al.,	
2013).	 However,	 it	 is	 difficult	 to	 exclude	 the	 possibility	 that	 the	 symptoms	 of	 precancerous	
conditions,	 or	 early	 cancer	 symptoms,	 led	 to	 patients	 having	 CT	 scans.	 Retrospective	 studies	
that	 seek	 to	 establish	 risk	 factors	 after	 disease	 diagnosis	 are	 especially	 susceptible	 to	 such	
reverse	causation.	
	
Confounders	 are	 factors	 causally	 related	 to	 both	 the	 postulated	 risk	 factor	 and	 the	 disease	
under	 consideration.	 For	 instance,	 smoking	 has	 been	 associated	 with	 increased	 risk	 of	 CRC	




the	 association	 between	 smoking	 and	 CRC	 incidence.	 As	 such	 confounders	 are	 often	 not	
measured	in	observational	epidemiological	studies,	it	may	not	always	be	possible	to	control	for	
them	when	evaluating	risk	factors.	Furthermore,	unidentified	confounders	may	exist,	resulting	




The	 gold	 standard	 for	 inferring	 causality	 is	 a	 randomized	 control	 trial	 (RCT).	 Individuals	 in	 an	
RCT	 are	 randomly	 assigned	 to	 two	 or	 more	 groups,	 minimizing	 both	 selection	 bias	 and	
confounding.	As	groups	are	assigned	at	the	start	of	the	study,	reverse	causation	can	be	avoided.	
RCTs	are	however	often	not	possible	due	to	the	costs	or	the	time	required.	Furthermore,	RCTs	





determine	 the	 effect	 of	 an	 exposure	 on	 an	 outcome	 (Sheehan	 et	 al.,	 2008).	 In	 the	 general	
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population,	 germline	 variants	 tend	 to	 be	 randomly	 distributed	 with	 respect	 to	 most	 human	
traits.	 This	 occurs	 because	 of	 the	 fixed	 nature	 of	 germline	 genotypes	 and	Mendel’s	 laws	 of	
inheritance	 (i.e.	 segregation	and	 independent	assortment).	Using	germline	variants	as	proxies	
for	 an	 exposure	 therefore	 ensures	 that	 MR	 is	 less	 susceptible	 to	 biases	 that	 affect	 many	






MR	analyses	 involve	three	main	assumptions:	 (i)	 the	genetic	variants	used	as	 IVs	are	robustly	




hypothesis	 that	 the	 exposure	 is	 not	 causally	 related	 to	 the	outcome.	However,	 to	 accurately	
estimate	the	size	of	the	effect,	a	fourth	additional	assumption	is	required:	(iv)	all	associations	








on	 genetic	 variants	 and	 the	exposure	of	 interest,	 and	 another	 containing	 information	on	 the	
same	genetic	variants	and	the	considered	outcome	(Hartwig	et	al.,	2016).	For	many	risk	factors	
and	 cancers,	 GWAS	 containing	 data	 from	 tens	 or	 hundreds	 of	 thousands	 of	 individuals	 have	
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putative	 exposure	 and	outcome,	 or	 the	 failure	 to	 identify	 a	 true	 causal	 relationship	 (Burgess	




are	 independently	distributed	 from	the	genetic	association	with	 the	outcome;	an	assumption	
referred	 to	 as	 InSIDE	 (INstrument	 Strength	 Independent	 of	 Direct	 Effect).	 If	 the	 InSIDE	
assumption	is	satisfied,	then	MR-Egger	causal	effect	estimates	will	be	consistent	as	sample	size	
and	 the	 number	 of	 genetic	 variants	 increase	 (Burgess	 and	 Thompson,	 2017).	 Furthermore,	
under	the	InSIDE	assumption	the	MR-Egger	intercept	term	can	be	used	to	evaluate	the	average	
pleiotropic	effect	across	variants.	 If	 this	average	pleiotropic	effect	 is	 zero,	 then	 the	MR-Egger	
causal	 effect	 estimate	 will	 equal	 causal	 effect	 estimates	 from	 other	 regression-based	 MR	







can	produce	unbiased	estimates	of	a	 causal	effect	even	when	 the	majority	of	 IVs	are	 invalid.	
Further	methodological	 developments,	 such	 as	 latent	 causal	 variable	 (LCV)	models,	 allow	 for	
accurate	 inference	 of	 causal	 relationships,	 even	 when	 the	 exposure	 and	 outcome	 are	
genetically	correlated	(O'Connor	and	Price,	2018).	These	methods	also	have	their	disadvantages	
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however,	 with	 MR-Egger,	 median	 estimators	 and	 mode-based	 estimates	 generally	 achieving	








by	 some	biases,	 there	are	a	number	of	 limitations	 to	 the	approach.	MR	methods	 rely	on	 the	
availability	of	genetic	instruments	robustly	associated	with	the	exposure	of	interest	that	can	be	
used	as	proxies.	For	some	exposures,	such	as	obesity	and	height,	GWAS	containing	data	from	
hundreds	 of	 thousands	 of	 individuals	 have	 been	 completed,	 resulting	 in	 the	 identification	 of	
hundreds	 of	 exposure-associated	 SNPs	 that	 explain	 a	 high	 proportion	 of	 the	 genetically	
associated	exposure	(Yengo	et	al.,	2018).	For	other	exposures	no	or	few	associated	SNPs	have	
been	 identified,	 thereby	prohibiting	 their	 study	using	MR	 frameworks.	 If	 exposure-associated	











Although	 implemented	 in	 a	 number	 of	 studies	 (Ahmad	 et	 al.,	 2015;	 Gage	 et	 al.,	 2017),	
conventional	IV	approaches	in	a	two-sample	setting	may	not	accurately	estimate	the	effect	size	
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of	 a	 binary	 exposure,	 such	 as	 smoking	 initiation,	 on	 a	 binary	 outcome,	 such	 as	 disease	
diagnosis.	 Through	 simulation	 we	 previously	 evaluated	 whether	 IVW,	 weighted	 median	
estimators,	mode-base	estimates	and	MR-Egger	methods	provide	 reliable	estimates	of	 causal	
effects	 when	 considering	 binary	 exposures	 and	 binary	 outcomes	 (Disney-Hogg	 et	 al.,	 2018).	











Several	 studies	have	 investigated	 the	causal	 relationship	between	obesity-related	 factors	and	
CRC	risk.	In	a	study	of	9,254	CRC	cases	and	18,386	controls,	Jarvis	et	al.	(2016)	associated	body	
mass	 index	(BMI)	(OR:	1.23,	95%	CI:	1.02-1.49,	P=0.033),	childhood	obesity	(OR:	1.07,	95%	CI:	
1.03-1.13,	 P=0.018)	 and	 waist-hip	 ratio	 (WHR)	 (OR:	 1.59,	 95%	 CI:	 1.08-2.34,	 P=0.019)	 with	
increased	CRC	risk.	Gao	et	al.	(2016)	similarly	associated	adult	BMI	with	increased	CRC	risk	(OR:	
1.39,	95%	CI:	1.06-1.82,	P=0.016),	but	did	not	find	significant	associations	for	childhood	BMI	or	
WHR,	 possibly	 due	 to	 the	 smaller	 size	 of	 their	 study,	 which	 contained	 5,100	 CRC	 cases	 and	





the	 association	 between	 obesity	 and	 risk	 of	 CRC	 (Vansaun,	 2013).	 Observational	
epidemiological	 studies	 of	 adiponectin	 have	 however	 yielded	 inconsistent	 results,	with	 some	
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associating	 lower	 circulating	 adiponectin	with	 increased	 CRC	 risk	 (Aleksandrova	 et	 al.,	 2012),	
and	others	failing	to	identify	such	association	(Stocks	et	al.,	2008).	MR	analyses	of	adiponectin	
and	 CRC	 risk	 have	 also	 been	 inconsistent.	 In	 a	 multi-ethnic	 meta-analysis,	 Pei	 et	 al.	 (2015)	




adiponectin-associated	SNPs	and	 similarly	did	not	 find	any	 to	be	 significantly	 associated	with	




Hyperinsulinemia	 has	 also	 been	 suggested	 to	 be	 associated	 with	 increased	 risk	 of	 CRC.	
Nimptsch	 et	 al.	 (2015b)	 therefore	 used	 an	MR	 framework	 to	 investigate	whether	 fetuin-A,	 a	
liver	 protein	 known	 to	 inhibit	 the	 action	 of	 insulin,	 was	 causally	 related	 to	 CRC	 risk.	 No	





2015).	 It	 is	 not	 clear	 however	whether	 these	 findings	 reflect	 a	 causal	 relationship	 or	 are	 the	




CRC	 risk	 is	highly	 controversial,	with	a	 recent	meta-analysis	of	eight	RCTs	 failing	 to	 identify	a	
significant	beneficial	effect	(Lytras	et	al.,	2014).	Other	analyses	have	however	associated	statin	
usage	 with	 lower	 CRC	 incidence	 (Mamtani	 et	 al.,	 2016).	 Rodriguez-Broadbent	 et	 al.	 (2017)	













depends	 solely	 on	 the	quantity,	 but	 also	 on	 the	 specific	 fatty	 acid	 (FA)	 type.	 Epidemiological	
studies	 and	 animal	 models	 have	 implicated	 animal	 fat	 (Reddy,	 2002),	 some	 omega-6	
polyunsaturated	 fatty	acids	 (PUFAs)	and	saturated	 fatty	acid	 (SFA)	with	 increased	cancer	 risk,	
and	omega-3	PUFA	consumption	with	reduced	cancer	risk	(Azrad	et	al.,	2013).	The	evidence	of	
a	 causal	 relationship	 between	 the	 consumption	 of	 specific	 fatty	 acids	 from	 observational	
epidemiological	 studies	 has	 however	 been	 inconclusive.	 Possible	 reasons	 for	 this	 include	
reverse	 causation,	 confounding	 factors	 and	 inaccurate	 measurement	 of	 long-term	 diet	
(Theodoratou	et	al.,	2007).	Results	from	an	MR	study	by	May-Wilson	et	al.	(2017)	were	broadly	
consistent	 with	 a	 pro-inflammatory	 FA	 profile	 having	 a	 detrimental	 effect	 on	 risk	 of	 CRC.	
Arachidonic	acid	(OR:	1.05,	95%	CI:	1.02-1.07,	P=1.7×10-4)	and	stearic	saturated	FAs	(OR:	1.17,	
95%	CI:	1.01-1.35,	P=0.041)	were	associated	with	increased	CRC	risk,	whilst	oleic	(OR:	0.77,	95%	




multiple	 FAs	 and	 risk	of	 CRC.	 These	 SNPs	were	used	assuming	 that	 the	exposure	 individually	
accounts	 for	 the	effect	on	CRC,	and	 the	effect	of	 the	genetic	variant	on	CRC	 risk	 is	 therefore	





Chronic	 inflammation	has	been	 identified	as	a	 risk	 factor	 for	CRC	 (Grivennikov,	2013).	Higher	
concentrations	 of	 C-reactive	 protein	 (CRP),	 a	 marker	 of	 inflammation,	 have	 been	 associated	
with	 an	 increased	 risk	 of	 CRC	 in	 observational	 epidemiological	 studies	 (Tsilidis	 et	 al.,	 2008).	
Considering	only	observational	studies	it	is	unclear	however	whether	this	relationship	is	causal,	
or	a	result	of	confounding	factors.	Wang	et	al.	(2018)	conducted	the	largest	MR	analysis	of	CRP	
concentration	 and	 CRC	 risk	 to-date,	 and	 failed	 to	 find	 evidence	 that	 CRP	 concentrations	 are	
causally	related	to	risk	of	CRC.	Nimptsch	et	al.	(2015a)	conversely	found	a	positive	relationship	
between	CRP	concentrations	and	CRC	risk	(OR:	1.74,	95%	CI:	1.06-2.85).	However,	the	study	by	
Nimptsch	 et	 al.	 (2015a)	 considered	 only	 727	 CRC	 cases	 and	 727	 controls,	whilst	Wang	 et	 al.	




leukemia,	 non-Hodgkin	 lymphoma	 and	 malignant	 melanoma	 (Green	 et	 al.,	 2011).	 GWAS	 of	
height	 encompassing	 more	 than	 half	 a	 million	 individuals	 have	 been	 conducted,	 identifying	
SNPs	 that	 explain	 a	 substantial	 proportion	 of	 height	 variation	 (Yengo	 et	 al.,	 2018),	 and	MR	
frameworks	are	therefore	well	suited	to	investigate	the	causal	relationship	between	height	and	
CRC.	 Using	 data	 from	 10,226	 CRC	 cases	 and	 10,286	 controls,	 Thrift	 et	 al.	 (2015a)	 found	 a	
positive	 association	 between	 height	 and	 CRC	 risk	 (OR:	 1.07,	 95%	 CI:	 1.01-1.14).	 In	 a	 smaller	
study	 of	 5,100	 cases	 and	 4,831	 controls,	 Khankari	 et	 al.	 (2016)	 also	 reported	 a	 positive	
association	(OR:	1.58,	95%	CI:	1.14-2.18,	P=0.006).	
	
Epidemiological	 studies	 of	 the	 effect	 of	 reproductive	 factors	 on	 risk	 of	 CRC	 have	 not	 been	






number	 of	 CRC	 cases	 and	 controls,	 it	 had	 limited	 power	 to	 detect	 weak	 causal	 effects.	
Nevertheless,	 these	 results	 suggest	 that	 it	 is	 unlikely	 that	 age	 at	menarche	 and	menopause	
have	substantial	causal	effects	on	CRC	risk.		
	
Polymorphisms	 altering	 the	 conversion	 rates	 of	 alcohol-metabolizing	 enzymes,	 leading	 to	 a	
build-up	 of	 excess	 acetaldehyde	 and	 thereby	 reducing	 heavy	 alcohol	 use,	 are	 prevalent	 in	
certain	Asian	populations	(Eng	et	al.,	2007).	These	polymorphisms,	such	as	Glu487Lys	in	ALDH2,	
therefore	 offer	 the	 opportunity	 to	 use	 MR	 frameworks	 to	 investigate	 the	 effect	 of	 alcohol	
consumption	 on	 various	 traits.	Wang	 et	 al.	 (2011)	 conducted	 a	meta-analysis	 of	MR	 studies	
using	the	Glu487Lys	polymorphism	to	examine	the	relationship	between	alcohol	consumption	
and	 risk	 of	 CRC,	 finding	 higher	 genetically	 predicted	 alcohol	 intake	 to	 be	 associated	 with	
increased	CRC	risk	(OR:	1.31,	95%	CI:	1.01-1.70).	The	lower	frequency	of	these	enzyme-altering	
alleles	in	non-Asian	populations	limits	the	use	of	MR	to	study	risk	factors	in	other	groups.	Large	
projects	 such	 as	 UK	 Biobank,	 which	 has	 genotyped	 SNPs	 and	 collected	 data	 on	 alcohol	
consumption	 in	 approximately	 500,000	 individuals	 (Bycroft	 et	 al.,	 2018),	 have	 led	 to	 the	




Dimitrakopoulou	 et	 al.	 (2017)	 used	 an	 MR	 strategy	 to	 investigate	 the	 relationship	 between	











al.,	 2016).	 An	 MR	 analysis	 of	 circulating	 IL-6	 concentrations	 and	 cancer	 risk	 was	 therefore	
performed	 by	 Tian	 et	 al.	 (2015),	 who	 did	 not	 find	 evidence	 of	 a	 causal	 relationship.	 This	 is	
concordant	 with	 the	 results	 of	 observational	 epidemiological	 studies,	 which	 have	 also	 not	
identified	IL-6	concentrations	to	be	associated	with	CRC	risk	(Zhou	et	al.,	2014).		
	
One	 of	 the	 earliest	 studies	 to	 use	 an	 MR	 framework	 to	 investigate	 CRC	 risk	 factors	 was	
conducted	by	Lin	et	al.	(2002),	who	used	a	polymorphism	in	PTGS2	(Val511Ala)	to	simulate	the	
effects	of	aspirin,	and	 thereby	 study	 the	 relationship	between	aspirin	use	and	CRC	 risk.	Non-
significant	 negative	 associations	 between	 the	 aspirin-simulating	 allele	 and	 CRC	 risk	 were	










identified	 no	 significant	 association	 between	 telomere	 length	 and	 CRC	 diagnosis	 (Zee	 et	 al.,	








Whilst	MR	has	provided	 supporting	evidence	 for	a	number	of	 known	and	 suspected	CRC	 risk	
factors	 (Table	 1),	 there	 are	 many	 other	 putative	 CRC	 risk	 factors	 that	 have	 not	 yet	 been	
interrogated	 using	 MR	 frameworks,	 including	 coffee	 consumption	 and	 intake	 of	 foods	
containing	 calcium,	 iron	 or	 zinc	 (World	 Cancer	 Research	 Fund,	 2017).	 For	 some	exposures,	 a	





So	 far,	MR	 analyses	 of	 CRC	 risk	 have	 generally	 been	 hypothesis-driven	 (i.e.	 have	 considered	
exposures	 for	which	 there	 is	pre-existing	evidence	 for	an	effect	on	CRC	 risk).	Hypothesis-free	
MR	 has	 the	 potential	 to	 identify	 previously	 unsuspected	 risk	 factors	 not	 considered	 in	







disequilibrium	 between	 SNPs	 (Zhu	 et	 al.,	 2018),	 thereby	 avoiding	 the	 unnecessary	 loss	 of	
information.	LCV	models	can	identify	causal	relationships	between	genetically	correlated	traits,	
mediating	 such	 correlations	 with	 latent	 causal	 variables	 (O'Connor	 and	 Price,	 2018).	 This	







Mendelian	 randomization	 has	 provided	 evidence	 supporting,	 and	 not	 supporting,	 the	 causal	
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Adiponectin	 Song	et	al.	(2015)	 7,020	 7,631	 No	significant	association.			
	 Nimptsch	et	al.	(2017)	 1,253	 1,627	 No	significant	association.			




Neumeyer	et	al.	(2018)	 12,944	 10,741	 No	significant	association.		
Alcohol		 Wang	et	al.	(2011)	 2,392	 3,951	 Alcohol	consumption	associated	with	increased	CRC	risk	(OR:	
1.31,	95%	CI:	1.01-1.70).	
Aspirin	 Lin	et	al.	(2002)	 161	 219	 No	significant	association.			
C-reactive	
protein	(CRP)	
Wang	et	al.	(2018)	 30,480	 22,844	 No	significant	association.			
Nimptsch	et	al.	(2015a)	 727	 727	 CRP	concentration	associated	with	increased	CRC	risk	(OR:	
1.74,	95%	CI:	1.06-2.85).	







Fetuin-A	 Nimptsch	et	al.	(2015b)	 456	 456	 No	significant	association.			
Height	 Thrift	et	al.	(2015a)	 10,226	 10,286	 Height	associated	with	increased	CRC	risk	(OR:	1.07,	95%	CI:	
1.01-1.14).		
	 Khankari	et	al.	(2016)	 5,100	 4,831	 Height	associated	with	increased	CRC	risk	(OR:	1.58,	95%	CI:	
1.14-2.18,	P=0.006).		
Interleukin-6	 Tian	et	al.	(2015)	 10,257	 12,391	 No	significant	association.			










	 Thrift	et	al.	(2015b)	 10,226	 10,286	 BMI	associated	with	increased	CRC	risk	(OR:	1.50,	95%	CI:	
1.13-2.01).	









Zhang	et	al.	(2015)	 5,100	 4,831	 No	significant	association.			
Vitamin	D	 Dimitrakopoulou	et	al.	(2017)	 11,488	 84,418	 No	significant	association.			
	 He	et	al.	(2018)	 10,725	 30,794	 No	significant	association.				
	 Theodoratou	et	al.	(2012)	 2,001	 2,237	 No	significant	association.		
	
Table	1:	MR	studies	that	have	assessed	a	possible	causal	relationship	between	exposures	and	
CRC	risk.	
